Actively hiring
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$175M
3 rounds on record
Latest round
$15M
Venture round · Dec 2018 · 7 yr ago
Team
1,402
US Form 5500 (plan participants) · Dec 2024
Backers
2
RA Capital Management, Sofinnova Partners
The money's age
Long since its last round
93 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 6, 2018
Raised a round Venture round $15M · SEC Form D
2017
Founded
Nov 10, 2016
Raised a round Venture round $80M · SEC Form D
Nov 10, 2016
Raised a round Venture round $80M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2018 | $15M | — | SEC Form D |
| Venture round | Nov 2016 | $80M | — | SEC Form D |
| Venture round | Nov 2016 | $80M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | ShockWave Medical, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Daniel HawkinsExecutive Officer, DirectorSEC Form D
Dan PuckettExecutive OfficerSEC Form D
Doug GodshallExecutive Officer, DirectorSEC Form D
Douglas GodshallExecutive Officer, DirectorSEC Form D
Isaac ZachariasExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

On a mission to transform the future of autoimmune care. Developing innovative therapies with the potential to redefine the standard of…

MuscleSound’s clinical decision-making software and ultrasound analytics solution equips healthcare providers with a new standard of care.

Terrestrial is transforming the delivery of next-generation therapies, starting with GLP-1. Terrestrial.

Vitara is a biomedical technology company reinventing the standard of care for extremely premature newborns.

Odyssey is on a mission to transform the standard of care for patients affected by autoimmune and inflammatory conditions.

AISAP redefines the standard of care with FDA-cleared diagnostic algorithms, embedded in an AI operating system for any POCUS device.
Visa sponsorship
- United States · H-1B filings in 12 months: 20 · green card filings: 1
People

Daniel Hawkins
Executive Officer, Director

Dan Puckett
Executive Officer

Doug Godshall
Executive Officer, Director

Douglas Godshall
Executive Officer, Director

Isaac Zacharias
Executive Officer

Frederic Moll
Director

Todd Brinton
Director

Jay Watkins
Director

Colin Cahill
Director

Antoine Papiernik
Director

Michael Sjostrom
Director

Marc-Andre Marcotte
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Fremont
United States
HQ
Santa Clara
United States
Regional office
Accessibility
5403 Betsy Ross Drive, Santa Clara, CA 95054, United States

RA Capital Management
Sofinnova Partners 




